Skip to main content

BVF Inc

SEC CIK
0001056807
Latest filing
Aug 14, 2026

ELDN holding history

Eledon Pharmaceuticals, Inc. in every 13F filed by BVF Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELDN overviewAll 13F holders of ELDNFull Q2 2026 holdings

Shares (Q2 2026)
6,293,282
Value
$24.8M
% of portfolio
0.6%
Quarters held
22
Since Q1 2021
Holdings of ELDN by BVF Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,293,282$24.8M0.6%00.0%UnchangedHolders
Q1 20266,293,282$19.4M0.6%00.0%UnchangedHolders
Q4 20256,293,282$9.50M0.3%00.0%UnchangedHolders
Q3 20256,293,282$16.3M0.7%00.0%UnchangedHolders
Q2 20256,293,282$17.1M0.6%00.0%UnchangedHolders
Q1 20256,293,282$21.3M0.9%00.0%UnchangedHolders
Q4 20246,293,282$25.9M0.9%00.0%UnchangedHolders
Q3 20246,293,282$15.7M0.5%00.0%UnchangedHolders
Q2 20246,293,282$16.6M0.5%+1,966,572+45.5%AddedHolders
Q1 20244,326,710$8.91M0.2%00.0%UnchangedHolders
Q4 20234,326,710$7.79M0.2%00.0%UnchangedHolders
Q3 20234,326,710$5.93M0.2%00.0%UnchangedHolders
Q2 20234,326,710$5.93M0.2%+2,000,000+86.0%AddedHolders
Q1 20232,326,710$5.49M0.2%00.0%UnchangedHolders
Q4 20222,326,710$5.40M0.2%00.0%UnchangedHolders
Q3 20222,326,710$6.42M0.3%00.0%UnchangedHolders
Q2 20222,326,710$5.68M0.3%00.0%UnchangedHolders
Q1 20222,326,710$9.17M0.4%+948,690+68.8%AddedHolders
Q4 20211,378,020$6.08M0.2%+14,585+1.1%AddedHolders
Q3 20211,363,435$8.43M0.3%+250,000+22.5%AddedHolders
Q2 20211,113,435$8.81M0.3%00.0%UnchangedHolders
Q1 20211,113,435$11.9M0.4%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.